Non-small cell lung cancer: an update on emerging EGFR-targeted therapies-Reference-Cited by-同舟云学术

Non-small cell lung cancer: an update on emerging EGFR-targeted therapies

Published:2024-04-02 Issue:2 Volume:29 Page:139-154
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Favorito Valentina¹²^ORCID,Ricciotti Ilaria¹²,De Giglio Andrea¹²,Fabbri Laura¹²,Seminerio Renata¹²,Di Federico Alessandro¹²^ORCID,Gariazzo Eleonora³,Costabile Silvia³,Metro Giulio³

Affiliation:

1. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

2. Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

3. Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2024.2331139

Reference159 articles.

1. Targeting EGFR Exon 20 Insertions in Non–Small Cell Lung Cancer: Recent Advances and Clinical Updates

2. Driven by Mutations: The Predictive Value of Mutation Subtype in EGFR -Mutated Non–Small Cell Lung Cancer

3. First-Generation Epidermal Growth Factor Receptor Inhibitors Plus Antiangiogenic Drugs Versus Third-Generation Epidermal Growth Factor Receptor Inhibitors in Advanced Non–Small-Cell Lung Cancer: A Meta-Analysis

4. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

5. Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Encouraging Fussy Eaters in EGFR-Mutated Lung Cancer;Journal of Thoracic Oncology;2024-08

2. Synthesis and biological research of new imidazolone-sulphonamide-pyrimidine hybrids as potential EGFR-TK inhibitors and apoptosis-inducing agents;RSC Advances;2024